Average Co-Inventor Count = 9.87
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Intellectual Property Gmbh (7 from 721 patents)
2. Bayer Healthcare Aktiengesellschaft (3 from 76 patents)
3. Bayer Pharma Aktiengesellschaft (2 from 378 patents)
4. Bayer Schering Pharma Ag (2 from 192 patents)
5. Bayer Aktiengesellschaft (1 from 12,157 patents)
6. Bayer Schering Pharma Aktiengellschaft (1 from 1 patent)
15 patents:
1. 10519154 - 7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof
2. 10435403 - Positive allosteric modulators of muscarinic M2 receptor
3. 9051316 - Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use
4. 8987256 - Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof
5. 8487111 - Substituted oxazolidinones and their use
6. 8436180 - Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
7. 8404709 - Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
8. 8399471 - Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the same
9. 8329716 - Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors
10. 7998988 - Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders
11. 7737153 - Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
12. 7723347 - Substituted phenylamino-pyrimidines
13. 7498460 - Isophthalic acid derivatives
14. 7173037 - Carbamate-substituted pyrazolopyridines
15. 7135474 - Derivatives of 2-(1-benzyl-1H-pyrazolo(3,4-B)pyridine-3-yl)-5(-4-pyridinyl)l-4-pyrimidinamines and the use thereof as quanylate cyclase stimulators